🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/05/2011 | 66,61 | 67,21 | 65,96 | 66,15 | -1,18% | 1,88% | 629.400 |
| 04/05/2011 | 67,85 | 68,54 | 66,82 | 66,94 | -0,98% | 2,54% | 623.400 |
| 03/05/2011 | 68,12 | 68,30 | 66,60 | 67,60 | -0,92% | 2,50% | 590.500 |
| 02/05/2011 | 66,96 | 69,01 | 66,71 | 68,23 | +1,90% | 3,43% | 765.200 |
| 29/04/2011 | 67,59 | 67,69 | 66,50 | 66,96 | -1,03% | 1,76% | 895.000 |
| 28/04/2011 | 70,38 | 70,38 | 66,78 | 67,66 | -4,30% | 5,12% | 2.300.000 |
| 27/04/2011 | 70,10 | 70,74 | 69,26 | 70,70 | +0,73% | 2,11% | 667.000 |
| 26/04/2011 | 70,39 | 70,74 | 69,80 | 70,19 | +0,27% | 1,34% | 445.900 |
| 25/04/2011 | 69,67 | 70,09 | 69,18 | 70,00 | -0,16% | 1,31% | 394.900 |
| 21/04/2011 | 69,26 | 70,70 | 68,67 | 70,11 | +1,36% | 2,93% | 607.900 |
| 20/04/2011 | 67,68 | 69,18 | 67,53 | 69,17 | +3,29% | 2,44% | 616.200 |
| 19/04/2011 | 66,39 | 67,00 | 66,37 | 66,97 | +0,98% | 0,95% | 679.800 |
| 18/04/2011 | 65,82 | 66,59 | 65,45 | 66,32 | +0,30% | 1,73% | 889.000 |
| 15/04/2011 | 66,53 | 66,95 | 65,97 | 66,12 | -1,05% | 1,47% | 749.500 |
| 14/04/2011 | 65,82 | 67,08 | 65,54 | 66,82 | +0,59% | 2,34% | 450.000 |
| 13/04/2011 | 66,53 | 66,79 | 66,07 | 66,43 | +0,15% | 1,08% | 493.400 |
| 12/04/2011 | 65,79 | 66,35 | 65,62 | 66,33 | +0,35% | 1,11% | 465.700 |
| 11/04/2011 | 65,85 | 66,58 | 65,39 | 66,10 | +0,44% | 1,81% | 516.800 |
| 08/04/2011 | 66,67 | 66,99 | 65,52 | 65,81 | -0,93% | 2,20% | 424.500 |
| 07/04/2011 | 67,16 | 67,69 | 66,36 | 66,43 | -1,50% | 1,98% | 656.800 |
| 06/04/2011 | 68,93 | 69,01 | 66,77 | 67,44 | -1,50% | 3,25% | 721.300 |
| 05/04/2011 | 68,18 | 69,29 | 67,94 | 68,47 | +0,48% | 1,98% | 731.700 |
| 04/04/2011 | 67,88 | 68,19 | 66,99 | 68,14 | +1,11% | 1,77% | 516.500 |
| 01/04/2011 | 67,49 | 67,75 | 67,10 | 67,39 | +0,55% | 0,96% | 715.900 |
| 31/03/2011 | 66,82 | 67,23 | 66,26 | 67,02 | +0,28% | 1,45% | 515.900 |
| 30/03/2011 | 65,58 | 67,38 | 65,58 | 66,83 | +2,41% | 2,74% | 663.400 |
| 29/03/2011 | 64,34 | 65,39 | 64,34 | 65,26 | +1,52% | 1,63% | 931.800 |
| 28/03/2011 | 65,78 | 65,86 | 63,88 | 64,28 | -2,32% | 3,01% | 918.300 |
| 25/03/2011 | 66,48 | 66,94 | 65,78 | 65,81 | -0,36% | 1,74% | 677.000 |
| 24/03/2011 | 65,54 | 66,50 | 64,88 | 66,05 | +1,38% | 2,47% | 714.900 |